BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32699674)

  • 21. Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study.
    Khera S; Mahajan D; Barbind K; Dhingra S
    Cancer Chemother Pharmacol; 2023 Apr; 91(4):331-336. PubMed ID: 36951972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia.
    Kinoshita A; Kurosawa Y; Kondoh K; Suzuki T; Manabe A; Inukai T; Sugita K; Nakazawa S
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):256-60. PubMed ID: 12655445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination.
    Ebid AIM; Hossam A; El Gammal MM; Soror S; Mangoud NOM; Mahmoud MA
    J Chemother; 2022 Oct; 34(6):381-390. PubMed ID: 34895107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical application of the simultaneous detection of methotrexate and 7-hydroxymethotrexate in the delayed elimination for pediatric acute lymphoblastic leukemia].
    Luo GJ; Wang L; Hu GF; Li CB; Liu HX; Peng MT
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1973-1978. PubMed ID: 32629599
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
    Gros L; Roldán A; Cabero-Martínez A; Domínguez-Pinilla N; de la Fuente A; González-Barca E; Tasso M; Torrent M; Gallardo E; Del Cerro I; Giró-Perafita A; Badia X
    J Oncol Pharm Pract; 2023 Jun; 29(4):794-801. PubMed ID: 35147457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients.
    Mirza MA; D Aruna ; Konatam ML
    Int J Health Sci (Qassim); 2023; 17(2):3-9. PubMed ID: 36891042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).
    Skärby T; Jönsson P; Hjorth L; Behrentz M; Björk O; Forestier E; Jarfelt M; Lönnerholm G; Höglund P
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):311-20. PubMed ID: 12721759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin.
    Vaishnavi K; Bansal D; Trehan A; Jain R; Attri SV
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27241. PubMed ID: 29768710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
    Diachinsky M; Tran T; Jupp J; McKinnon K
    J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of glucarpidase (carboxypeptidase-G2) in pediatric cancer patients: 11-year experience of a tertiary center.
    Vila R; Rubio-San-Simón A; Zubiaur P; Navares-Gómez M; Gómez-Hernández P; Arce B; Madero L
    EJHaem; 2023 Nov; 4(4):1052-1058. PubMed ID: 38024601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing delayed high-dose methotrexate excretion and its correlation with adverse reactions after treatment in children with malignant hematological tumors.
    Yu L; Shen J; Li H; Zhang M; Wang Z; Gao Y; Chen J; Li J
    Transl Pediatr; 2024 Feb; 13(2):300-309. PubMed ID: 38455749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe administration of high-dose methotrexate with minimal drug level monitoring: Experience from a center in north India.
    Dhingra H; Kalra M; Mahajan A
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28394. PubMed ID: 32813334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients.
    Gallais F; Oberic L; Faguer S; Tavitian S; Lafont T; Marsili S; Brice A; Chatelut E; Puisset F
    Ther Drug Monit; 2021 Jun; 43(3):408-415. PubMed ID: 32925658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects with intravenous methotrexate in children with acute lymphoblastic leukemia/lymphoma: a retrospective study.
    Mandal P; Samaddar S; Chandra J; Parakh N; Goel M
    Indian J Hematol Blood Transfus; 2020 Jul; 36(3):498-504. PubMed ID: 32647424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia.
    Donelli MG; Zucchetti M; Robatto A; Perlangeli V; D'Incalci M; Masera G; Rossi MR
    Med Pediatr Oncol; 1995 Mar; 24(3):154-9. PubMed ID: 7838036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Dose Methotrexate: Nursing Considerations for Administration and Supportive Care.
    Roche B; Clarke PA; Ford D; Collins Shaver S; Thompson J
    Clin J Oncol Nurs; 2023 Jan; 27(1):47-54. PubMed ID: 37677820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survey of Methotrexate Prescription and Blood Concentration in Patients Treated with High-Dose Methotrexate].
    Kobayashi S; Yasu T; Momo K; Ohno N
    Gan To Kagaku Ryoho; 2020 Jul; 47(7):1063-1067. PubMed ID: 32668853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate.
    Yang SL; Zhao FY; Song H; Shen DY; Xu XJ
    ScientificWorldJournal; 2015; 2015():751703. PubMed ID: 26185782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.
    O'Donoghue DF; Truong HL; Finnes HD; McDonald JS; May HP; Ansell SM; Bennani NN; Habermann TM; Inwards DJ; Johnston PB; Khurana A; Lin Y; Micallef IN; Nowakowski GS; Paludo J; Porrata LF; Thanarajasingam G; Thompson CA; Villasboas JC; Wang Y; Witzig TE; Leung N
    JCO Oncol Pract; 2022 Dec; 18(12):e1908-e1917. PubMed ID: 36240468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia.
    Cheng DH; Lu H; Liu TT; Zou XQ; Pang HM
    Chemotherapy; 2018 Apr; 63(2):101-107. PubMed ID: 29672292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.